Market Tracker

09/01 4:45pm ET

Avanir Pharmaceuticals Inc (NASDAQ:AVNR)

6.22
Data as of Aug 29
 +0.21 / +3.49%
Today’s Change
2.62
Today|||52-Week Range
6.24
+85.12%
Year-to-Date

Today’s Trading

Previous close6.01
Today’s open6.03
Day’s range5.97 - 6.22
Volume1,600,737
Average volume (3 months)2,001,071
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 08/29/2014

Growth & Valuation

Earnings growth (last year)-17.78%
Earnings growth (this year)+44.91%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+82.59%
P/E ratioNM
Price/Sales7.99
Price/Book51.21

Competitors

 Today’s
change
Today’s
% change
TSROTESARO Inc+0.16+0.54%
LGNDLigand Pharmaceutica...+0.08+0.15%
ACHNAchillion Pharmaceut...+0.12+1.05%
EPZMEpizyme Inc+0.31+0.91%
Data as of 3:59pm ET, 08/29/2014

Financials

Next reporting dateNovember 25, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$75.4M
Annual profit (last year)-$75.5M
Net profit margin-100.15%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Keith A. Katkin
Secretary &
Vice President-Finance
Christine G. Ocampo
Corporate headquarters
Aliso Viejo, California

Forecasts